Action of β-phenylethylamine and related amines on nigrostriatal dopamine neurotransmission

European Journal of Pharmacology

Volumn 297, Issue 3, 1996, Pages 195-203

  Barroso, Natalia ^a   Rodriguez, Manuel ^a,b  

^a UNIVERSIDAD DE LA LAGUNA   (Spain)

^b UNIVERSIDAD DE LA LAGUNA   (Spain)

Author keywords

Dopamine; Nigrostriatal system; Rotation; Phenylethylamine

Indexed keywords

1 (3,5 DIFLUOROBENZYL) 2 IMIDAZOLETHIOL; AMINE; APOMORPHINE; DOPAMINE; DOPAMINE BETA HYDROXYLASE INHIBITOR; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; DOPAMINE UPTAKE INHIBITOR; HALOPERIDOL; METIROSINE; MONOAMINE OXIDASE B INHIBITOR; N (2 PHENYLETHYL)ACETAMIDE; OXIDOPAMINE; PHENETHYLAMINE; PHENYLACETALDEHYDE; PHENYLETHANOLAMINE; RESERPINE; SELEGILINE; TYRAMINE; TYROSINE HYDROXYLASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INJURY; CIRCLING BEHAVIOR; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINE UPTAKE; DOPAMINERGIC TRANSMISSION; DOSE RESPONSE; DRUG ANTAGONISM; DRUG POTENTIATION; ENZYME INHIBITION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029670894     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(95)00757-1     Document Type: Article

References (48)

1. Antelman, S.M., D.L. Edwardsand and M. Lin, 1977, Phenylethylamine: evidence for a direct, postsynaptic dopamine-receptor stimulating action, Brain Res. 127, 317.
2. Bailey, B.A., S.R. Philips and A.A. Boulton, 1987, In vivo release of endogenous dopamine, 5-hydroxytryptamine and some of their metabolites from rat caudate nucleus by phenylethylamine, Neurochem. Res. 12, 173.
3. Boulton, A.A., A.V. Juorio, S.R. Philips and P.H. Wu, 1977, Effects of reserpine and 6-hydroxydopamine on the levels of some arylalkylamines in the rat brain, Br. J. Pharmacol. 59, 209.
4. Boulton, A.A., B.A. Davis, P.H. Yu, J.S. Wormith and D. Addington, 1983, Trace acid levels in the plasma and monoamine oxidase activity in the platelets of violent offenders, Psychiatry Res. 8, 19.
5. Burunat, E., M.D. Diaz-Palarea, R. Castro and M. Rodriguez, 1987, Undrugged rotational response in nigro-striatal system-lesioned rats is related to the previous early response to apomorphine when repeatedly administered, Life Sci. 41, 309.
6. Burunat, E., R. Castro, M.D. Diaz-Palarea and M. Rodriguez, 1988, Conditioning of the early behavioral response to apomorphine in the rotational model of Parkinson's disease, Eur. J. Pharmacol. 145, 323.
7. 3H-acetylcholine from slices of the rat striatum: involvement of dopamine receptors, Eur. J. Pharmacol. 87, 167.
8. Castro, R., P. Abreu, C.H. Calzadilla and M. Rodriguez, 1985, Increased or decreased locomotor response in rats following repeated administration of apomorphine depends on dosage intervals, Psychopharmacology 85, 333.
9. Dourish, C.T., 1982a, An observational analysis of the behavioural effects of β-phenylethylamine in isolated and grouped mice, Prog. Neuro-Psychopharmacol. Biol. Psychiat. 6, 143.
10. Dourish, C.T., 1982b, A pharmacological analysis of the hyperactivity syndrome induced by β-phenylethylamine in the mouse, Br. J. Pharmacol. 77, 129.
11. Dourish, C.T. and S.J Cooper, 1984a, Environmental experience produces qualitative changes in the stimulant effects of β-phenylethylamine in rats, Psychopharmacology 84, 132.
12. Dourish, C.T. and S.J. Cooper, 1984b, Potentiation of total horizontal activity and ambulation in rats treated with combinations of β-phenylethylamine and naloxone, Neuropharmacology 23, 1059.
13. Dourish, C.T., A.J. Greenshaw and A.A. Boulton, 1983, Deuterium substitution enhances the effects of β-phenylethylamine on spontaneous motor activity in the rat, Pharmacol. Biochem. Behav. 19, 471.
14. Dyck, L.E., 1983, Release of monoamines from striatal slices by phenelzine and β-phenylethylamine, Prog. Neuropsychopharmacol. Biol. Psychiatry 7, 797.
15. Dyck, L.E., C.R. Yang and A.A. Boulton, 1983, The biosynthesis of p-tyramine, m-tyramine, and β-phenylethylamine by rat striatal slices, J. Neurochem. Res. 10, 211.
16. Durden, D.A. and S.R. Philips, 1980, Kinetic measurements of the turnover rates of phenylethylamine and tryptamine in vivo in the rat brain, J. Neurochem. 34, 1725.
17. Durden, D.A., S.R. Philips and A.A. Boulton, 1973, Identification and distribution of β-phenylethylamine in the rat, Can. J. Biochem. 51, 995.
18. Greenshaw, A., A.V. Juorio and T.V. Nguyen, 1986, Depletion of striatal β-phenylethylamine following dopamine but not 5-HT denervation, Brain Res. Bull. 17, 477.
19. Harms, P.G. and S.R. Ojeda, 1974, A rapid and simple procedure for chronic cannulation of the rat jugular vein, J. Appl. Physiol. 36, 391.
20. 3H]β-phenylethylamine binding sites in rat brain, Eur. J. Pharmacol. 83, 147.
21. Henry, D.P., W. Russell, J.A. Clements and L.A. Plebus, 1988, Phenylethylamine and p-tyramine in the extracellular space of the rat brain: quantification using a new radioenzymatic assay and in situ microdialysis, in: Trace Amines: Comparative and Clinical Neurobiology, eds. A.A. Boulton, A.V. Juorio and R.G.H. Downer (Humana Press, Clifton, NJ) p. 239.
22. Jackson, D.M. and D.B. Smythe, 1973, The distribution of β-phenylethylamine in discrete regions of the rat brain and its effect on brain noradrenaline, dopamine and 5-hydroxytryptamine levels, Neuropharmacology 12, 663.
23. Juorio, A.V., I.A. Paterson, M.Y. Zhu and G. Matte, 1991, Electrical stimulation of the substantia nigra and changes of 2-phenylethylamine synthesis in the rat striatum, J. Neurochem. 56, 213.
24. Liang N.Y. and C.O. Rutledge, 1982, Evidence for carrier-mediated efflux of dopamine from corpus striatum, Biochem. Pharmacol. 31, 2479.
25. Marsden, C.D., 1980, 'On-Off phenomena in Parkinson's disease, in: Parkinson's Disease - Current Progress, Problems and Management, eds. U.K. Rinne, M. Klinger and G. Stamm (Elsevier, Amsterdam) p. 241.
26. McMillen, B.A., 1983, CNS stimulants: two distinct mechanisms of action for amphetamine-like drugs, Trends Pharmacol. Sci. 4, 429.
27. Moore, K.E., 1977, The actions of amphetamine on neurotransmitters: a brief review, Biol. Psychiatry 12, 451.
28. Nakagawara, M., 1992, β-Phenylethylamine and noradrenergic function in depression, Prog. Neuro-Psychopharmacol. Biol-Psychiat. 16, 45.
29. Nguyen, T.V., D. O'Regan, K.M. Dewar and A.J. Greenshaw, 1986, Assessment of possible direct postsynaptic effects of d-amphetamine and of β-phenylethylamine in vivo, Proc. West. Pharmacol. Soc. 29, 271.
30. Obeso, J.A., F. Grandas, J. Vaamonde, M.R. Luquin, J. Artieda, G. Lera, M.E. Rodriguez and J.M. Martinez-Lage, 1989, Motor complications associated with chronic levodopa therapy in Parkinson's disease, Neurology 39 (Suppl. 2), 11.
31. Ohlstein, E.H., L.I. Kruse, M. Ezekiel and R.N. Willette, 1988, Further characterization of the cardiovascular effects of the dopamine-m-hydroxylase inhibitor SK and F 102698 in conscious hypertensive rats, J. Pharmacol. Exp. Ther. 247, 186.
32. Ortmann, R., M. Schaub, A. Felner, J. Lauber, P. Christen and P.C. Waldmeier, 1984, Phenylethylamine-induced stereotypes in the rat: a behavioral test system for assessment of MOA-B inhibitors, Psychopharmacology 84, 22.
33. Parker, E.M. and L.X. Cubeddu, 1986, Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores, J. Pharmacol. Exp. Ther. 237, 179.
34. Paterson, I.A., A.V. Juorio and A.A. Boulton, 1990, 2-Phenylethylamine: a modulator of catecholamine transmission in the mammalian central nervous system?, J. Neurochem. 55, 1827.
35. Philips, S.R., 1986, In vivo release of endogenous dopamine from rat caudate nucleus by β-phenylethylamine and α, α-dideutero-β-phenylethylamine, Life Sci. 39, 2395.
36. Philips, S.R. and A.M. Robson, 1983, In vivo release of endogenous dopamine from the rat caudate nucleus by phenylethylamine, Neuropharmacology 22, 1297.
37. Philips, S.R., B. Rozdilsky and A.A. Boulton, 1978, Evidence for the presence of m-tyramine, tryptamine and phenylethylamine in the rat brain and several areas of human brain, Biol. Psychiatry 13, 51.
38. Potkin, S.G., F. Karoum, L.W. Chuang, H.E. Cannon-Spoor, Y. Philips and R.J. Wyatt, 1979, Phenylethylamine in paranoid chronic schizophrenia, Science 206, 470.
39. Raiteri, M., R. Del Carmen, A. Bertollini and G. Levi, 1977, Effect of sympathomimetic amines on the synaptosomal transport of noradrenaline, dopamine, and 5-hydroxytryptamine, Eur. J. Pharmacol. 41, 133.
40. Reynolds, G.P., M. Sandler, J. Hardy and H. Bradford, 1980, The determination and distribution of 2-phenylethylamine in sheep brain, J. Neurochem. 34, 1123.
41. Saavedra J.M., 1989, β-Phenylethylamine, phenylethanolamine, tyramine and octopamine, in: Catecholamines II, eds. U. Trendelenburg and N. Weiner (Springer-Verlag, Berlin) p. 181.
42. Sabelli, H.C., J. Fawcett, F. Gusovsky, J. Javaid, J. Edwards and H. Jeffries, 1983, Urinary phenyl acetate: a diagnostic test for depression?, Science 225, 1187.
43. Sandler, M., C.R.J. Ruthven, B.L. Goodwin and A. Coppen, 1979, Clin. Chim. Acta 93, 169.
44. Seeman, P., 1981, Brain dopamine receptors, Pharmacol. Rev. 32, 229.
45. Szymanski, H.V., E.W. Nailor and F. Karoum, 1987, Plasma phenylethylamine and phenylalanine in chronic schizophrenic patients, Biol. Psychiatry 22, 194.
46. Ungerstedt, U., 1971, Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system, Acta Physiol. Scand. Suppl. 367, 69.
47. Wu, P.H. and A.A. Boulton, 1975, Metabolism, distribution and disappearance of injected β-phenylethylamine in the rat, Can. J. Biochem. 53, 42.
48. Yu, P.H., R. Bowen, B.A. Davis and A.A. Boulton, 1983, Platelet monoamine oxidase activity and trace acid levels in plasma of agoraphobic patients, Acta Psychiatry Scand. 67, 188.